Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Acta Neurochir (Wien) ; 149(6): 629-32; discussion 632, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17460817

RESUMEN

Aspergillosis of the central nervous system (CNS) is a rare, but well described disease in immuno-competent patients. We present a 65-year-old patient who developed neuro-aspergillosis 10 months after severe cranio-facial trauma (Le Fort III). He was treated successfully with surgery including stereotactic drainage and, with Amphotericin B, Liposomal Amphotericin B, and Itraconazol.


Asunto(s)
Absceso Encefálico/inmunología , Traumatismos Faciales/cirugía , Inmunocompetencia/inmunología , Fracturas Maxilares/cirugía , Meningitis Fúngica/inmunología , Neuroaspergilosis/inmunología , Complicaciones Posoperatorias/inmunología , Fracturas Craneales/cirugía , Anciano , Anfotericina B/administración & dosificación , Antifúngicos/administración & dosificación , Absceso Encefálico/diagnóstico , Absceso Encefálico/tratamiento farmacológico , Absceso Encefálico/cirugía , Ventrículos Cerebrales/cirugía , Derivaciones del Líquido Cefalorraquídeo , Terapia Combinada , Esquema de Medicación , Humanos , Hidrocefalia/cirugía , Itraconazol/administración & dosificación , Masculino , Meningitis Fúngica/diagnóstico , Meningitis Fúngica/tratamiento farmacológico , Meningitis Fúngica/cirugía , Microcirugia , Corteza Motora/cirugía , Neuroaspergilosis/diagnóstico , Neuroaspergilosis/tratamiento farmacológico , Neuroaspergilosis/cirugía , Neuronavegación , Osteotomía Le Fort , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/tratamiento farmacológico , Complicaciones Posoperatorias/cirugía , Reoperación , Tomografía Computarizada por Rayos X
2.
Int J Antimicrob Agents ; 27(1): 77-80, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16352422

RESUMEN

Three Escherichia coli isolates resistant to third-generation cephalosporins but negative for extended-spectrum beta-lactamase production were isolated from hospitalised patients in Zagreb, Croatia, during June 2003 to February 2004. Resistance was due to the inducible production of a DHA-1 cephalosporinase. Each isolate contained an integron-associated bla(DHA-1)-ampR sequence carried by similar-sized plasmids, of which one was self-transferable. Serotyping and polymerase chain reaction typing using ERIC2 primer indicated that the isolates were distinct. This is the first description of DHA beta-lactamase production in E. coli.


Asunto(s)
Resistencia a las Cefalosporinas/genética , Cefalosporinasa/genética , Proteínas de Escherichia coli/genética , Escherichia coli/genética , Proteínas Bacterianas/genética , Cefalosporinas/farmacología , Conjugación Genética , Croacia , Escherichia coli/efectos de los fármacos , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/microbiología , Transferencia de Gen Horizontal , Pruebas de Sensibilidad Microbiana , Plásmidos/genética , Reacción en Cadena de la Polimerasa/métodos , beta-Lactamas/farmacología
3.
J Chemother ; 23(6): 341-4, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22233817

RESUMEN

As a cost-saving measure, the Drug and Therapeutics Committee (DTC) removed ceftriaxone from the list of restricted antibiotics in May, 2008, which permitted its use as a first-line antibiotic. To evaluate the impact of this change, the occurrence of extended-spectrum beta-lactamase (ESBL)-positive bacterial strains and antibiotic consumption were monitored for 2 years before and after the intervention. In the post-intervention period, ceftriaxone utilization increased, while total antibiotic utilization did not change significantly. The utilization of all restricted antibiotics decreased (p <0.05) in the post-intervention period. Utilization of carbapenems increased (p <0.05), while utilization of quinolones increased nonsignificantly. The density of resistant ESBLs increased (p = 0.001) from 0.99 to 1.34 per 1000 bed-days from the pre- to the postintervention period. Ceftriaxone use was significantly correlated with ESBL occurrence (p <0.005). It can be concluded that ceftriaxone de-restriction increased the occurrence of ESBLs and the utilization of carbapemens.


Asunto(s)
Antibacterianos/uso terapéutico , Bacterias/efectos de los fármacos , Bacterias/enzimología , Ceftriaxona/uso terapéutico , Utilización de Medicamentos/estadística & datos numéricos , beta-Lactamasas/biosíntesis , Revisión de la Utilización de Medicamentos , Humanos
4.
Infection ; 24(1): 26-8, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8852459

RESUMEN

In laryngectomized patients, the nose does not function. The absence of a physiological airflow stimulus leads to clinical, cytologic and histologic changes of the nasal mucosa. The aim of this study was to identify the nasal cavity bacterial flora in these patients and to determine whether or not it undergoes changes with time. In a group of 25 patients, the nasal mucosa swabs were taken before, and 8 days and 1 month after the surgery. In a group of 15 patients, the nasal mucosa swabs were taken 1 to 2 years postoperatively.


Asunto(s)
Candida/aislamiento & purificación , Bacterias Gramnegativas/aislamiento & purificación , Bacterias Grampositivas/aislamiento & purificación , Laringectomía/efectos adversos , Cavidad Nasal/microbiología , Mucosa Nasal/microbiología , Adulto , Anciano , Enterobacter/aislamiento & purificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proteus mirabilis/aislamiento & purificación , Pseudomonas aeruginosa/aislamiento & purificación , Staphylococcus aureus/aislamiento & purificación , Staphylococcus epidermidis/aislamiento & purificación , Streptococcus/aislamiento & purificación , Streptococcus pneumoniae/aislamiento & purificación , Factores de Tiempo
5.
Transfus Med ; 14(3): 237-40, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15180816

RESUMEN

Bacterial contamination of blood products causes significant patient morbidity and mortality. Contaminated platelet transfusion is a frequent cause of bacteraemia and sepsis because of the storage conditions of platelets. A fatal case of Morganella morganii platelet transfusion associated with sepsis is described, along with procedures traced back to the isolation of M. morganii from a donor's stool. Molecular typing was performed, and the same M. morganii strain was found in blood and post-mortem organ cultures of platelet recipient and platelet bag and in the donor's stool. The route of contamination is unknown. The contamination could be due to either insufficient venipuncture site disinfection or the donor's transient bacteraemia. Patient died 5 days after the transfusion.


Asunto(s)
Infecciones por Enterobacteriaceae/transmisión , Morganella morganii/aislamiento & purificación , Transfusión de Plaquetas/efectos adversos , Sepsis/microbiología , Adulto , Técnicas de Tipificación Bacteriana , Donantes de Sangre , Infecciones por Enterobacteriaceae/diagnóstico , Resultado Fatal , Heces/microbiología , Femenino , Humanos , Leucemia Mieloide Aguda/complicaciones , Leucemia Mieloide Aguda/terapia , Masculino , Persona de Mediana Edad , Sepsis/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA